Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP716578.RA2eVGQ0K8ST2Jugv6h9P7LNlmSVIDdrIgWFyk01fIE6g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP716578.RA2eVGQ0K8ST2Jugv6h9P7LNlmSVIDdrIgWFyk01fIE6g130_assertion type Assertion NP716578.RA2eVGQ0K8ST2Jugv6h9P7LNlmSVIDdrIgWFyk01fIE6g130_head.
- NP716578.RA2eVGQ0K8ST2Jugv6h9P7LNlmSVIDdrIgWFyk01fIE6g130_assertion description "[HC2 and GP5+/6+, have shown in large clinical trials that they perform better in the detection of CIN 2+/CIN 3+ lesions than cytology and thus have been clinically validated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP716578.RA2eVGQ0K8ST2Jugv6h9P7LNlmSVIDdrIgWFyk01fIE6g130_provenance.
- NP716578.RA2eVGQ0K8ST2Jugv6h9P7LNlmSVIDdrIgWFyk01fIE6g130_assertion evidence source_evidence_literature NP716578.RA2eVGQ0K8ST2Jugv6h9P7LNlmSVIDdrIgWFyk01fIE6g130_provenance.
- NP716578.RA2eVGQ0K8ST2Jugv6h9P7LNlmSVIDdrIgWFyk01fIE6g130_assertion SIO_000772 20129067 NP716578.RA2eVGQ0K8ST2Jugv6h9P7LNlmSVIDdrIgWFyk01fIE6g130_provenance.
- NP716578.RA2eVGQ0K8ST2Jugv6h9P7LNlmSVIDdrIgWFyk01fIE6g130_assertion wasDerivedFrom befree-20140225 NP716578.RA2eVGQ0K8ST2Jugv6h9P7LNlmSVIDdrIgWFyk01fIE6g130_provenance.
- NP716578.RA2eVGQ0K8ST2Jugv6h9P7LNlmSVIDdrIgWFyk01fIE6g130_assertion wasGeneratedBy ECO_0000203 NP716578.RA2eVGQ0K8ST2Jugv6h9P7LNlmSVIDdrIgWFyk01fIE6g130_provenance.